Context

Luxempart acquired a substantial minority stake in Alphacaps GmbH. The deal is meticulously designed to establish a long-term, highly aligned partnership between the historical owners and the incoming financial sponsor. By providing a flexible capital solution, Luxempart injects fresh momentum into the enterprise, perfectly equipping the incumbent management team with the vital strategic backing and resources required to actively execute their ongoing development roadmap. The primary objective of this new alliance is to massively accelerate the target's expansion within the fast-growing European nutritional supplements market.

Target

Alphacaps is a leading full-service contract developer and manufacturer specifically dedicated to the nutritional and food supplements industry. Benefiting from deep sector know-how and state-of-the-art production machinery, the enterprise holds all the required certifications to manufacture a comprehensive variety of high-quality formulations and formats. The firm operates within a rapidly expanding market and heavily differentiates itself through its uncompromising product quality, relentless focus on customer satisfaction, and exceptional agility in rapidly adapting to ever-changing consumer trends. Driven by robust operational fundamentals, the company is ideally positioned to capitalize on structural market growth.